Whole-body vibration training for patients with neurodegenerative disease

The Cochrane Database of Systematic Reviews
Mercè Sitjà RabertXavier Bonfill Cosp

Abstract

Whole-body vibration (WBV) may be a complementary training to standard physical rehabilitation programmes and appears to have potential benefits in the sensorimotor system performance of patients with neurodegenerative diseases. The aim of this review was to examine the efficacy of WBV to improve functional performance according to basic activities of daily living (ADL) in neurodegenerative diseases. Additionally, we wanted to assess the possible effect on signs and symptoms of the disease, body balance, gait, muscle performance, quality of life and adverse events. We searched the following electronic databases: the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, 2011 Issue 4), MEDLINE (1964 to 6 May 2011; via PubMed), EMBASE (1980 to 6 May 2011; via Ovid), PeDro (1929 to May 2011; via website), CINAHL (to September 2011; via Ovid) and PsycINFO (1806 to 6 May 2011; via Ovid). We included randomised controlled trials comparing single or multiple sessions of WBV to a passive intervention, any other active physical therapy or WBV with different vibration parameters. Two review authors independently selected trials for inclusion, assessed trial quality and extracted data. Disagreement was resolved by...Continue Reading

Associated Clinical Trials

References

Sep 1, 1966·Experimental Neurology·G Eklund, K E Hagbarth
Jan 29, 1999·BMJ : British Medical Journal·A H Schapira
Apr 17, 2002·Lancet·Alastair Compston, Alasdair Coles
Feb 4, 2003·Exercise and Sport Sciences Reviews·Marco Cardinale, Carmelo Bosco
Dec 12, 2003·Archives of Physical Medicine and Rehabilitation·Cosimo Roberto RussoLuigi Ferrucci
Mar 26, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Clinton RubinKenneth McLeod
Mar 26, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Sabine M P VerschuerenSteven Boonen
May 27, 2004·Journal of the American Geriatrics Society·Machteld RoelantsSabine M Verschueren
Jun 8, 2004·Current Drug Targets. CNS and Neurological Disorders·Michael J O'NeillEric S Nisenbaum
Nov 13, 2004·The Journal of Nutritional Biochemistry·S P Brooks, B J Lampi
Nov 25, 2004·Physical Medicine and Rehabilitation Clinics of North America·James H Rimmer
Dec 18, 2004·Archives of Physical Medicine and Rehabilitation·Paul L de VreedeHarald J Verhaar
Jan 18, 2005·Sports Medicine·Jin LuoKieran Moran
Feb 12, 2005·Archives of Physical Medicine and Rehabilitation·Olivier BruyereJean-Yves Reginster
May 21, 2005·Journal of Strength and Conditioning Research·Matthew J JordanWalter Herzog
Jul 27, 2005·Multiple Sclerosis : Clinical and Laboratory Research·Robert W MotlErin M Snook
Dec 6, 2005·Clinical Rehabilitation·Othmar SchuhfriedTatjana Paternostro-Sluga
Dec 20, 2005·Lancet·Cleusa P FerriUNKNOWN Alzheimer's Disease International
Jan 6, 2006·Research in Sports Medicine·Stephan TurbanskiPetra Duisberg
Mar 4, 2006·The Journal of the British Menopause Society·Marco Cardinale, Jörn Rittweger
May 16, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Peter FeysXuguang Liu
Jul 11, 2006·Journal of Exposure Science & Environmental Epidemiology·Jonathan WilsonPatricia McLaine
Nov 30, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Samyra H J KeusUNKNOWN Practice Recommendations Development Group
Jan 12, 2007·Research in Sports Medicine·Christian T HaasDietmar Schmidtbleicher
Apr 20, 2007·The Cochrane Database of Systematic Reviews·F KhanT Kilpatrick
Jun 28, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·An BogaertsSabine M P Verschueren
Jul 3, 2007·Archives of Physical Medicine and Rehabilitation·Wing-Hoi CheungKwok-Sui Leung
Sep 21, 2007·Multiple Sclerosis : Clinical and Laboratory Research·U DalgasT Ingemann-Hansen
Sep 27, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Michael J FalvoGammon M Earhart
Oct 3, 2007·Medicine and Science in Sports and Exercise·Andrew F J AbercrombyWilliam H Paloski
Dec 1, 2007·Journal of Aging and Physical Activity·Sven ReesMark Watsford
Feb 20, 2008·Annals of Internal Medicine·Isabelle BoutronUNKNOWN CONSORT Group
Feb 26, 2008·Archives of Physical Medicine and Rehabilitation·Georg EbersbachJoerg Wissel
Jun 14, 2008·Journal of Science and Medicine in Sport·Sven S ReesMark L Watsford
Jan 28, 2009·Disability and Rehabilitation. Assistive Technology·Kamiar GhoseiriAhlam Bavi
Feb 10, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Pablo AriasJavier Cudeiro
Mar 7, 2009·Journal of Neurologic Physical Therapy : JNPT·Kurt J JacksonC Jayne Brahler
Mar 18, 2009·Age and Ageing·Katherine Brooke-Wavell, Neil J Mansfield

❮ Previous
Next ❯

Citations

Sep 28, 2017·The Cochrane Database of Systematic Reviews·Julia BidondeCatherine Boden
Aug 8, 2013·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·J SecoL C Abecia Inchaurregui
Jan 15, 2019·The Cochrane Database of Systematic Reviews·Bhasker AmatyaMary Galea
Apr 10, 2019·European Journal of Physical and Rehabilitation Medicine·William M LevackE Jean Hay-Smith
Jan 14, 2021·Brain Sciences·Ida CariatiGiovanna D'Arcangelo
Jan 16, 2020·European Journal of Physical and Rehabilitation Medicine·Silvia MarazziAndrea Turolla
Jun 4, 2021·Frontiers in Human Neuroscience·Trevor S BarssAmit N Pujari

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.